Graphene is composed of single-atom thick sheets of sp2 bonded carbon atoms that are arranged in a perfect two-dimensional (2D) honeycomb lattice. Because of this structure, graphene is characterized by a number of unique and exceptional structural, optical, and electronic properties.1 Specifically, these extraordinary properties include, but are not limited to, a high planar surface area that is calculated to be 2630 m2 g−1,2 superior mechanical strength with a Young’s modulus of 1100 GPa,3 unparalleled thermal conductivity (5000 W m−1 K−1),4 remarkable electronic properties (e.g., high carrier mobility [10 000 cm2 V−1 s−1] and capacity),5 and alluring optical characteristics (e.g., high opacity [~97.7%] and the ability to quench fluorescence).6 As such, it should come as no surprise that graphene is currently, without any doubt, the most intensively studied material for a wide range of applications that include electronic, energy, and sensing outlets.1c Moreover, because of these unique chemical and physical properties, graphene and graphene-based nanomaterials have attracted increasing interest, and, arguably, hold the greatest promise for implementation into a wide array of bioapplications.7 In the last several years, numerous studies have utilized graphene in bioapplications ranging from the delivery of chemotherapeutics for the treatment of cancer8 to biosensing applications for a host of medical conditions9 and even for the differentiation and imaging of stem cells.10 While promising and exciting, recent reports have demonstrated that the combination of graphene with nanomaterials such as nanoparticles, thereby forming graphene–nanoparticle hybrid structures, offers a number of additional unique physicochemical properties and functions that are both highly desirable and markedly advantageous for bioapplications when compared to the use of either material alone (Figure 1).11 These graphene–nanoparticle hybrid structures are especially alluring because not only do they display the individual properties of the nanoparticles, which can already possess beneficial optical, electronic, magnetic, and structural properties that are unavailable in bulk materials, and of graphene, but they also exhibit additional advantageous and often synergistic properties that greatly augment their potential for bioapplications. Open in a separate window Figure 1 Graphene nanoparticle hybrids exist in two forms, as graphene–nanoparticle composites and graphene-encapsulated nanoparticles, and can be used for various bioapplications including biosensors, photothermal therapies, stem cell/tissue engineering, drug/gene delivery, and bioimaging. Panel (A) reprinted with permission from ref 110. Copyright 2012 Wiley. Panel (B) reprinted with permission from ref 211. Copyright 2013 Elsevier. Panel (C) reprinted with permission from ref 244. Copyright 2013 Wiley.
Read full abstract